Free Trial

Cytek Biosciences (CTKB) Competitors

Cytek Biosciences logo
$3.61 +0.13 (+3.74%)
Closing price 04:00 PM Eastern
Extended Trading
$3.56 -0.05 (-1.52%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTKB vs. TXG, TRNS, EYPT, ALNT, LAB, AEHR, QSI, QTRX, SENS, and MASS

Should you be buying Cytek Biosciences stock or one of its competitors? The main competitors of Cytek Biosciences include 10x Genomics (TXG), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Senseonics (SENS), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

Cytek Biosciences vs. Its Competitors

10x Genomics (NASDAQ:TXG) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

In the previous week, 10x Genomics had 9 more articles in the media than Cytek Biosciences. MarketBeat recorded 12 mentions for 10x Genomics and 3 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.91 beat 10x Genomics' score of 0.90 indicating that Cytek Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
10x Genomics
5 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cytek Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 10.3% of Cytek Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cytek Biosciences has lower revenue, but higher earnings than 10x Genomics. Cytek Biosciences is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
10x Genomics$610.78M2.62-$182.63M-$1.30-10.01
Cytek Biosciences$200.45M2.28-$6.02M-$0.09-40.11

Cytek Biosciences has a net margin of -5.71% compared to 10x Genomics' net margin of -25.14%. Cytek Biosciences' return on equity of -2.90% beat 10x Genomics' return on equity.

Company Net Margins Return on Equity Return on Assets
10x Genomics-25.14% -23.22% -18.02%
Cytek Biosciences -5.71%-2.90%-2.30%

10x Genomics has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500.

10x Genomics currently has a consensus target price of $14.96, suggesting a potential upside of 15.00%. Cytek Biosciences has a consensus target price of $5.60, suggesting a potential upside of 55.12%. Given Cytek Biosciences' higher possible upside, analysts clearly believe Cytek Biosciences is more favorable than 10x Genomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
10x Genomics
1 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.43
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

10x Genomics and Cytek Biosciences tied by winning 8 of the 16 factors compared between the two stocks.

Get Cytek Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTKB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTKB vs. The Competition

MetricCytek BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$440.77M$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E Ratio-40.117.3718.7020.12
Price / Sales2.28278.47414.67113.66
Price / Cash100.2841.4736.1356.90
Price / Book1.187.518.055.38
Net Income-$6.02M-$55.05M$3.15B$248.50M
7 Day Performance8.41%2.45%1.85%2.97%
1 Month Performance27.56%7.33%4.81%6.02%
1 Year Performance-35.54%5.38%34.86%20.39%

Cytek Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTKB
Cytek Biosciences
3.0027 of 5 stars
$3.61
+3.7%
$5.60
+55.1%
-38.0%$440.77M$200.45M-40.11500News Coverage
TXG
10x Genomics
4.645 of 5 stars
$11.58
-1.3%
$14.96
+29.2%
-35.1%$1.44B$610.78M-8.911,240
TRNS
Transcat
2.9649 of 5 stars
$85.96
+1.3%
$114.00
+32.6%
-26.9%$790.33M$278.42M55.101,245
EYPT
Eyepoint Pharmaceuticals
2.4297 of 5 stars
$9.41
-2.4%
$25.67
+172.8%
+14.9%$663.34M$43.27M-3.90120
ALNT
Allient
2.674 of 5 stars
$36.31
+1.1%
$31.00
-14.6%
+50.5%$608.09M$529.97M61.542,525News Coverage
LAB
Standard BioTools
3.5241 of 5 stars
$1.20
+0.8%
$2.50
+108.3%
-25.4%$451.99M$174.43M-3.43620Positive News
AEHR
Aehr Test Systems
4.0413 of 5 stars
$12.93
+3.3%
$25.00
+93.3%
+27.1%$372.74M$66.22M16.5890News Coverage
Gap Up
QSI
Quantum-Si
2.433 of 5 stars
$1.96
+0.5%
$3.48
+77.3%
+103.3%$357.82M$3.06M-2.88150Positive News
QTRX
Quanterix
2.8539 of 5 stars
$6.65
flat
$15.60
+134.6%
-47.2%$332.20M$137.42M-5.12460
SENS
Senseonics
1.5329 of 5 stars
$0.48
-3.6%
$1.55
+225.4%
+20.2%$311.67M$23.68M-3.6690
MASS
908 Devices
1.6831 of 5 stars
$7.13
+5.9%
$5.33
-25.2%
+35.8%$241.35M$59.63M-13.2060

Related Companies and Tools


This page (NASDAQ:CTKB) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners